Generation of oxidant stress in cultured endothelial cells by methylene blue: Protective effects of glucose and ascorbic acid

Biochemical Pharmacology

Volumn 66, Issue 5, 2003, Pages 777-784

  May, James M ^a   Qu, Zhi Chao ^a   Whitesell, Richard R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ascorbic acid; Dihydrofluorescein; EA.hy926 endothelial cells; Ferricyanide; Methylene blue; Oxidant stress

Indexed keywords

ASCORBIC ACID; FERRICYANIDE; FLUORESCEIN; GLUCOSE; GLUTATHIONE; METHYLENE BLUE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; CELL PROTECTION; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REDUCTION;

EID: 0041428228     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00408-8     Document Type: Article

References (32)

1. Bongard R.D., Merker M.P., Shundo R., Okamoto Y., Roerig D.L., Linehan J.H., Dawson C.A. Reduction of thiazine dyes by bovine pulmonary arterial endothelial cells in culture. Am. J. Physiol. 269:1995;L78-L84.
2. Merker M.P., Bongard R.D., Linehan J.H., Okamoto Y., Vyprachticky D., Brantmeier B.M., Roerig D.L., Dawson C.A. Pulmonary endothelial thiazine uptake: separation of cell surface reduction from intracellular reoxidation. Am. J. Physiol. 272:1997;L673-L680.
3. Olson L.E., Merker M.P., Patel M.K., Bongard R.D., Daum J.M., Johns R.A., Dawson C.A. Cyanide increases reduction but decreases sequestration of methylene blue by endothelial cells. Ann. Biomed. Eng. 28:2000;85-93.
4. McCord J.M., Fridovich I. The utility of superoxide dismutase in studying free radical reactions. II. The mechanism of the mediation of cytochrome c reduction by a variety of electron carriers. J. Biol. Chem. 245:1970;1374-1377.
5. Metz E.N., Balcerzak S.P., Sagone A.L. Jr. Mechanisms of methylene blue stimulation of the hexose monophosphate shunt in erythrocytes. J. Clin. Invest. 58:1976;797-802.
6. Baird J.K. Methylene blue-mediated hexose monophosphate shunt stimulation in human red blood cells in vitro: independence from intracellular oxidative injury. Int. J. Biochem. 16:1984;1053-1058.
7. Sass M.D., Caruso C.J., Axelrod D.R. Mechanism of the TPNH-linked reduction of methemoglobin by methylene blue. Clin. Chim. Acta. 24:1969;77-85.
8. Gruetter C.A., Kadowitz P.J., Ignarro L.J. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. Can. J. Physiol. Pharmacol. 59:1981;150-156.
9. Mayer B., Brunner F., Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem. Pharmacol. 45:1993;367-374.
10. Kelner M.J., Bagnell R., Hale B., Alexander N.M. Methylene blue competes with paraquat for reduction by flavo-enzymes resulting in decreased superoxide production in the presence of heme proteins. Arch Biochem. Biophys. 262:1988;422-426.
11. Edgell C.J., McDonald C.C., Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U.S.A. 80:1983;3734-3737.
12. Preiser J.C., Lejeune P., Roman A., Carlier E., De Backer D., Leeman M., Kahn R.J., Vincent J.L. Methylene blue administration in septic shock: a clinical trial. Crit. Care Med. 23:1995;259-264.
13. Koelzow H., Gedney J.A., Baumann J., Snook N.J., Bellamy M.C. The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation. Anesth. Analg. 94:2002;824-829. [table].
14. Perriott L.M., Kono T., Whitesell R.R., Knobel S.M., Piston D.W., Granner D.K., Powers A.C., May J.M. Glucose uptake and metabolism by cultured human skeletal muscle cells: rate-limiting steps. Am. J. Physiol. Endocrinol. Metab. 281:2001;E72-E80.
15. Jones W., Li X., Perriott L.M., Whitesell R.R., May J.M. Uptake, recycling, and antioxidant functions of α-lipoic acid in endothelial cells. Free Radic. Biol. Med. 33:2002;83-93.
16. Hissin P.J., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74:1976;214-226.
17. May J.M., Qu Z.C., Li X. Requirement for GSH in recycling of ascorbic acid in endothelial cells. Biochem. Pharmacol. 62:2001;873-881.
18. Zerez C.R., Lee S.J., Tanaka K.R. Spectrophotometric determination of oxidized and reduced pyridine nucleotides in erythrocytes using a single extraction procedure. Anal. Biochem. 164:1987;367-373.
19. Li X., Hill K.E., Burk R.F., May J.M. GSH is required to recycle ascorbic acid in cultured liver cell lines. Antioxid. Redox. Signal. 3:2001;1089-1097.
20. May J.M., Qu Z.-C., Mendiratta S. Protection and recycling of α-tocopherol in human erythrocytes by intracellular ascorbic acid. Arch. Biochem. Biophys. 349:1998;281-289.
21. Avron M., Shavit N. A sensitive and simple method for determination of ferrocyanide. Anal. Biochem. 6:1963;549-554.
22. Székely M., Mányai S., Straub F.B. Über den Mechanismus der osmotischen Hämolyse. Acta Physiol. Acad. Sci. Hung. 3:1952;571-583.
23. Rose I.A., O'Connell E.L. The role of glucose 6-phosphate in the regulation of glucose metabolism in human erythrocytes. J. Biol. Chem. 239:1964;12-17.
24. Merker M.P., Bongard R.D., Kettenhofen N.J., Okamoto Y., Dawson C.A. Intracellular redox status affects transplasma membrane electron transport in pulmonary arterial endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:2002;L36-L43.
25. Kowaltowski AJ, Vercesi AE. Reactive oxygen generation by mitochondria. In: Lemasters JJ, Nieminen A-L, editors. Mitochondria in pathogenesis. New York: Kluwer Academic/Plenum Publishers; 2001. p. 281-300.
26. Hempel S.L., Buettner G.R., O'Malley Y.Q., Wessels D.A., Flaherty D.M. Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2′,7′-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic. Biol. Med. 27:1999;146-159.
27. May J.M., Qu Z.-C., Li X. Ascorbic acid blunts oxidant stress due to menadione in endothelial cells. Arch. Biochem. Biophys. 411:2003;136-144.
28. Wright R.O., Lewander W.J., Woolf A.D. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann. Emerg. Med. 34:1999;646-656.
29. Aeschlimann C., Cerny T., Küpfer A. Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue. Drug Metab. Dispos. 24:1996;1336-1339.
30. Küpfer A., Aeschlimann C., Cerny T. Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy. Eur. J. Clin. Pharmacol. 50:1996;249-252.
31. Golubuff N., Wheaton R. Methylene blue induced cyanosis and acute hemolytic anemia complicating the treatment of methemoglobinemia. J. Pediatr. 58:1961;86-89.
32. Sills M.R., Zinkham W.H. Methylene blue-induced Heinz body hemolytic anemia. Arch. Pediatr. Adolesc. Med. 148:1994;306-310.